Commentary: Type I CRISPR-Cas Targets Endogenous Genes and Regulates Virulence to Evade Mammalian Host Immunity
Overview
Authors
Affiliations
Wu Q, Cui L, Liu Y, Li R, Dai M, Xia Z Mol Biomed. 2022; 3(1):22.
PMID: 35854035 PMC: 9296731. DOI: 10.1186/s43556-022-00084-1.
Alternative functions of CRISPR-Cas systems in the evolutionary arms race.
Mohanraju P, Saha C, van Baarlen P, Louwen R, Staals R, van der Oost J Nat Rev Microbiol. 2022; 20(6):351-364.
PMID: 34992260 DOI: 10.1038/s41579-021-00663-z.
Digging into the lesser-known aspects of CRISPR biology.
Guzman N, Esquerra-Ruvira B, Mojica F Int Microbiol. 2021; 24(4):473-498.
PMID: 34487299 PMC: 8616872. DOI: 10.1007/s10123-021-00208-7.
Boudry P, Piattelli E, Drouineau E, Peltier J, Boutserin A, Lejars M RNA Biol. 2021; 18(11):1931-1952.
PMID: 33629931 PMC: 8583004. DOI: 10.1080/15476286.2021.1882180.
CRISPR-Cas Systems and the Paradox of Self-Targeting Spacers.
Wimmer F, Beisel C Front Microbiol. 2020; 10:3078.
PMID: 32038537 PMC: 6990116. DOI: 10.3389/fmicb.2019.03078.